Evidence map›Paper›PMID 33540616›Full record

ArticleCancers2021

Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.

Stefan Fiedler, Inge M Ambros, Evgenia Glogova, Martin Benesch, Christian Urban, Marlene Mayer, Georg Ebetsberger-Dachs, Edit Bardi, Neil Jones, Agnes Gamper and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 1 country.

Stefan FiedlerSt. Anna Children's Hospital, 1090 Vienna, Austria.ORCID 0000-0003-0581-8509
Inge M AmbrosCCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Evgenia GlogovaCCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Martin BeneschDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, 8036 Graz, Austria.
Christian UrbanDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, 8036 Graz, Austria.
Marlene MayerDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, 8036 Graz, Austria.
Georg Ebetsberger-DachsMed Campus IV, University Clinic for Pediatrics, Kepler University Hospital, 4020 Linz, Austria.
Edit BardiSt. Anna Children's Hospital, 1090 Vienna, Austria.
Neil JonesDepartment of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.
Agnes GamperDepartment of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.
Bernhard MeisterDepartment of Pediatric Hematology, Oncology, and Stem-Cell Transplantation, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Roman CrazzolaraDepartment of Pediatric Hematology, Oncology, and Stem-Cell Transplantation, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Gabriele AmannDepartment of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
Karin DieckmannDepartment of Radiotherapy, Medical University of Vienna, 1090 Vienna, Austria.
Ernst HorcherDepartment of Pediatric Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Reinhold KerblDepartment of Pediatric Medicine, Landeskrankenhaus Leoben, 8700 Leoben, Austria.
Bettina Brunner-HerglotzCCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Andrea ZieglerCCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Peter F AmbrosCCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.ORCID 0000-0002-5507-7211
Ruth LadensteinSt. Anna Children's Hospital, 1090 Vienna, Austria.
Medical University of Graz · ATMedical University of Vienna · ATInnsbruck Medical University · ATKepler Universitätsklinikum · ATParacelsus Medical University · ATSt Anna Children's Hospital · ATLandeskrankenhaus Feldkirch · AT

Funding

Austrian National Bank (OeNB), Vienna, Austria 16611Austrian Science Fund (FWF) I 2799-B28St. Anna Kinderkrebsforschung, Vienna, Austria -
6 · The paper itself

Abstract

We evaluated long-term outcome and genomic profiles in the Austrian Neuroblastoma Trial A-NB94 which applied a risk-adapted strategy of treatment (RAST) using stage, age and

Indexed as

Austrian trial A-NB94biomarkersneuroblastoma

Identifiers

PMID33540616
PMCPMC7867286
OpenAlexW3128958390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.